Premium In Vitro Diagnostics Market Research Reports
Some of Our Customers, Over The Past 2-Decades
INFECTIOUS DISEASE IVD MARKET REVIEW REPORT
September 2024 – 356 pages
MARKETS BY DISEASE, BY TYPE (POC/LAB), BY TECHNOLOGY (MOLECULAR, IMMUNOASSAY, PANELS), AND BY COUNTRY; IMPORTANT TRENDS, COMPANY PROFILES AND MORE
The report reveals over a dozen infectious disease areas that beat growth in the IVD market, including some testing areas that are doubling or tripling the revenue growth of the market.
ARTIFICIAL INTELLIGENCE IN IVD MARKETS
Published June 2024 – 540 pages
BY APPLICATION, BY TECHNOLOGY AND BY USER. WITH EXECUTIVE AND CONSULTANT GUIDES 2024-2028
Learn all about how players are jockeying for position in a market that is being created from scratch. Some players are pulling way out in front and expanding globally. It is a dynamic market situation with enormous opportunity, where the right diagnostic with the right support can command premium pricing.
This report provides data that analysts and planners can use. Hundreds of pages of information, including a complete list of United States Medicare Fee Payment Schedules to help understand the new pricing for nucleic acid-based tests.
Your report is provided on a 12-month subscription basis from the date you receive your first report. You will receive 2 or more updated versions of the complete report during the 12 months. At least one of these updates will provide forecasts based on next year’s data.
SYNDROMIC MULTIPLEX PANELS MARKETS
Published January 2024 – 555 pages
Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, GI etc.) by Place and by Product. With Market Analysis and Executive Guides
Infectious disease Dx is changing and will change more in the future. Can a rapidly growing market expand even faster? Find out all about it in this comprehensive report on Syndromic Multiplex Diagnostics.
Your report is provided on a 12-month subscription basis from the date you receive your first report. You will receive 2 or more updated versions of the complete report during the 12 months. At least one of these updates will provide forecasts based on next year’s data.
CONTRACT MANUFACTURING IN IVD MARKETS
Published November 2024 – 50 pages
BY APPLICATION, BY TECHNOLOGY AND BY COUNTRY. TRENDS, KEY MARKET GUIDANCE AND FORECASTS 2024-2029
This report, Contract Manufacturing in IVD, provides a comprehensive look at the marketplace for these services. As contract manufacturers do not generally publish revenues, this report is assembled as the result of interviews with contract organizations manufacturing for OEMs, assessed and synthesized by a knowledgeable IVD expert with contacts in manufacturing
LIQUID BIOPSY MARKETS “Has Liquid Biopsy crossed the chasm ?”
Published August 2024 – 585 pages
“LIQUID BIOPSY MARKETS BY CANCER, USAGE, BIOMARKER, PLACE, & PRODUCT WITH PRICE AND VOLUME OUTLOOK. INCLUDING EXECUTIVE AND CONSULTANT GUIDES AND CUSTOMIZED FORECASTING AND ANALYSIS 2024-2028″
The Screening, Diagnostic, Therapy Selection, Minimal Residual Disease and Screening Market Potential are all explored in this report. We look at Price and Volume Outlooks by type of cancer. This report provides detailed analysis.
Circulating Tumor Cells? Cell Free DNA? Exosomes? Find out about the technology in readily understood terms that explain the jargon. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size.
Your report is provided on a 12-month subscription basis from the date you receive your first report. You will receive 2 or more updated versions of the complete report during the 12 months. At least one of these updates will provide forecasts based on next year’s data.
Metagenomic Markets
Published January 2024 – 364 pages
“A game changer in diagnostics? New technology changes viewpoint on infections…”
Global Market Analysis with Forecasts by Applications, Technologies, Product and User. With Executive and Consultant Guides. 2025 to 2029″
Unlimited growth potential? A Game Changer? It is not exaggeration. Metagenomic assays could change the way medical treatment is done. Learn all about it in this new research report.
The role of genetics in health and disease is just now being understood. This new knowledge, combined with lower costs is driving a new type of genetic testing. Metagenomic Testing looks at all the genetic material in a sample. In the process it learns about infection, cancer, antimicrobial resistance, and the patient genome. It’s a whole new approach. Chronic infection? Find out the real culprits. Secrets of the microbiome and gut health? Metagenomics has the answers.
Your report is provided on a 12-month subscription basis from the date you receive your first report. You will receive 2 or more updated versions of the complete report during the 12 months. At least one of these updates will provide forecasts based on next year’s data.
SEPSIS MARKETS
Published June 2024 – 540 pages
BY APPLICATION, BY TECHNOLOGY AND BY USER. WITH EXECUTIVE AND CONSULTANT GUIDES 2024-2028
Diagnostics for sepsis are urgently needed and improvements are a constant concern. This creates an opportunity for test makers. But how to sum up this opportunity for reasonable business planning efforts? This report, Sepsis Markets, is a comprehensive review of the industry. The report looks at both the challenges and opportunities in the diagnostics for sepsis.
Your report is provided on a 12-month subscription basis from the date you receive your first report. You will receive 2 or more updated versions of the complete report during the 12 months. At least one of these updates will provide forecasts based on next year’s data.
Subscribe to EYE ON IVD
Get the latest news about the in vitro diagnostics market, from the experts.